American Association for Cancer Research

Table 1

Age, pTNM stage, grading, number of LOH/SHIFT of all patients

No.	Age (years)	pTNM^a	Grade^a	LOH (No.) Tumor/Serum^b
3018	66	T2 N0	3	3/0
3084	67	T3 N1	2	6/6
3190	70	T2 N0	3	0/3
3177	71	T3 N1	3	3/1
3049	61	T2 N0	3	5/6
2902	74	T4 N1 M1	3	4/5
3261	61	T3 N0	2	3/4
2663	74	T2 N1	2	1/4
2448	59	T2 N1 M1	2	6/3
2447	72	T3 N0	2	2/1
2364	46	T3 N0	2	3/2
2451	60	T3 N0	2	3/4
2758	52	T3 N0	3	4/3
2747	71	T1 N1	3	5/2
2445	37	T3 N1	3	4/4
2821	60	T3 N1	2	6/3
3270	52	T3 N1	3	7/3
3263	62	T1 N0	2	0/3
3323	63	T2 N0	2	3/2
3332	73	T3 N1	3	8/5
3373	70	T3 N1	2	1/1
3404	53	T2 N1	2	6/3
3417	53	T2 N1	2	2/2
2268	55	T3 N1	2	3/2
2752	52	T2 N1	3	3/3
2822	60	T2 N1	2	8/5
2638	65	T2 N1	2	3/3
3378	63	T3 N1	2	7/3

No.	Age (years)	pTNM^a	Grade^a	LOH (No.) Tumor/Serum^b
3018	66	T2 N0	3	3/0
3084	67	T3 N1	2	6/6
3190	70	T2 N0	3	0/3
3177	71	T3 N1	3	3/1
3049	61	T2 N0	3	5/6
2902	74	T4 N1 M1	3	4/5
3261	61	T3 N0	2	3/4
2663	74	T2 N1	2	1/4
2448	59	T2 N1 M1	2	6/3
2447	72	T3 N0	2	2/1
2364	46	T3 N0	2	3/2
2451	60	T3 N0	2	3/4
2758	52	T3 N0	3	4/3
2747	71	T1 N1	3	5/2
2445	37	T3 N1	3	4/4
2821	60	T3 N1	2	6/3
3270	52	T3 N1	3	7/3
3263	62	T1 N0	2	0/3
3323	63	T2 N0	2	3/2
3332	73	T3 N1	3	8/5
3373	70	T3 N1	2	1/1
3404	53	T2 N1	2	6/3
3417	53	T2 N1	2	2/2
2268	55	T3 N1	2	3/2
2752	52	T2 N1	3	3/3
2822	60	T2 N1	2	8/5
2638	65	T2 N1	2	3/3
3378	63	T3 N1	2	7/3

pTNM and grade according to the American Joint Committee on Cancer staging.

Numbers under LOH columns indicate positive microsatellite markers in tumor and serum DNA. In total 12 markers were tested by microsatellite analysis in each clinical sample.

View Large

This Feature Is Available To Subscribers Only